David C. Bibby

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 446 citations · Full text

Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice

David C. Bibby, James E. Talmadge, Milind K. Dalal et al. · International Journal of Pharmaceutics · 2005 · 133 citations

Nanomedicine, Drug Targeting, Nanotherapeutics +9

In vitro study of GDNF release from biodegradable PLGA microspheres

Anne Aubert‐Pouëssel, Marie‐Claire Venier‐Julienne, Anne Clavreul et al. · Journal of Controlled Release · 2004 · 123 citations

Tissue Engineering, Engineering, Biomaterials Design +7

A Novel in Vitro Delivery System for Assessing the Biological Integrity of Protein upon Release from PLGA Microspheres

Anne Aubert‐Pouëssel, David C. Bibby, Marie‐Claire Venier‐Julienne et al. · Pharmaceutical Research · 2002 · 63 citations

Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation

Danny Rischin, David C. Bibby, Geoff Chong et al. · Clinical Cancer Research · 2011 · 62 citations